Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug;76(4):1443-1452.
doi: 10.1007/s13304-024-01812-8. Epub 2024 Mar 26.

Changes in cardiac functions in patients treated with parathyroidectomy for secondary hyperparathyroidism

Affiliations

Changes in cardiac functions in patients treated with parathyroidectomy for secondary hyperparathyroidism

Sami Benli et al. Updates Surg. 2024 Aug.

Abstract

Our study aims to investigate the changes in cardiac functions, especially myocardial performance index (MPI), in patients who underwent parathyroidectomy for secondary hyperparathyroidism. Patients who underwent parathyroidectomy for secondary hyperparathyroidism between June 2010 and September 2021 were analyzed retrospectively. The patients were divided into two groups: those who underwent total parathyroidectomy (group 1) and those who underwent subtotal parathyroidectomy (group 2). The groups were compared according to the echocardiogram findings performed in the preoperative period and the postoperative sixth month. In addition, cardiac structure, and systolic and diastolic functions, especially myocardial performance index, were evaluated by echocardiography and Doppler imaging. Thirty-seven patients were examined; 16 (43.2%) underwent total parathyroidectomy, and 21 (56.8%) had subtotal parathyroidectomy performed. Group 1's mean left ventricular end-systolic diameter (LVES) decreased from 2.53 ± 0.57 to 2.35 ± 0.37 cm after parathyroidectomy. In Group 1, the postoperative value of LVES and end-systolic volume decreased significantly compared to the preoperative period (p = 0.042, p = 0.008, respectively). EF increased from 59.25 ± 0.05 to 67.81 ± 4.04. In Group 1, EF and EV postoperatively increased significantly compared to the preoperative period (p = 0.023, p = 0.021, respectively). The mean MPI decreased from 0.45 ± 0.07 to 0.39 ± 0.04 after parathyroidectomy in group 1. In group 2, it decreased from 0.46 ± 0.06 to 0.40 ± 0.04 (p < 0.001). The present study provides an improvement in myocardial functions after parathyroidectomy. While LVES, EF, ejection volume, end-systolic volume, and MPI improved in both groups, the MPI improvement was more evident in the total parathyroidectomy group.

Trial registration: ClinicalTrials.gov NCT06187480.

Keywords: Cardiac function; Myocardial performance index; Secondary hyperparathyroidism; Tei index.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1
Fig. 1
Myocardial performance index calculation. Measurement of right ventricular pre-ejection period (PEP), ejection time (ET), isovolumetric contraction time (ICT), isovolumetric relaxation time (IRT), and calculation of myocardial performance index (MPI)
Fig. 2
Fig. 2
Flow chart of the study

References

    1. Rodríguez-Ortiz ME, Rodríguez M (2020) Recent advances in understanding and managing secondary hyperparathyroidism in chronic kidney disease. F1000Res 9:F1000 Faculty Rev-1077. 10.12688/f1000research.22636.1 - PMC - PubMed
    1. van der Plas WY, Noltes ME, van Ginhoven TM, Kruijff S (2020) Secondary and tertiary hyperparathyroidism: a narrative review. Scand J Surg 109(4):271–278. 10.1177/1457496919866015 10.1177/1457496919866015 - DOI - PubMed
    1. Isakova T, Nickolas TL, Denburg M et al (2017) KDOQI US Commentary on the 2017 KDIGO clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Am J Kidney Dis 70(6):737–751. 10.1053/j.ajkd.2017.07.019 10.1053/j.ajkd.2017.07.019 - DOI - PubMed
    1. Ganesh SK, Stack AG, Levin NW, Hulbert-Shearon T, Port FK (2001) Association of elevated serum PO(4), Ca × PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 12(10):2131–2138. 10.1681/ASN.V12102131 10.1681/ASN.V12102131 - DOI - PubMed
    1. Moe SM, Chertow GM, Coburn JW et al (2005) Achieving NKF-K/DOQI bone metabolism and disease treatment goals with cinacalcet HCl. Kidney Int 67(2):760–771. 10.1111/j.1523-1755.2005.67139.x 10.1111/j.1523-1755.2005.67139.x - DOI - PubMed

Associated data

LinkOut - more resources